Discrepancies in TP53 status results obtained with different techniques may be an effect of difficulties in IHC interpretation, such as no assessment of positive internal control, the presence of artefacts, or tumor heterogeneity [73,74]. The gene discussed is TP53; the disease is neoplasm.